hemorrhagic internal hemorrhoids
Conditions
Interventions
Experimental group:Endoscopic sclerotherapy
Control group:Traditional hemorrhoidectomy
Sponsors
The Second People's Hospital of Yibin
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Aged between 18-75 years old; (2) Patients with hemorrhagic internal hemorrhoids accompanied by related symptoms, who meet the LrD0.1~Rf0-2 or LrDRf1-2 classification and have not responded to conservative treatments such as medication (with D > 1mm); (3) Elderly patients, those with hypertension, diabetes, or severe systemic diseases who are unable to tolerate surgical procedures; (4) Patients who have not undergone hemorrhoid procedures and/or hemorrhoid surgery before; (5) Voluntarily sign an informed consent form.
Exclusion criteria
Exclusion criteria: (1) Mixed hemorrhoids and external hemorrhoids; (2) Hemorrhagic internal hemorrhoids accompanied by complications such as incarceration, thrombosis, ulceration, infection, etc.; (3) Severe heart, brain, lung, liver, or kidney failure that cannot tolerate endoscopic treatment; (4) Patients with perianal infectious diseases, anal fistula, history of radiation therapy, or active inflammatory bowel disease; (5) Patients with rectal tumors; (6) Pregnant or postpartum women; (7) Patients with a history of mental illness; (8) Allergy to sclerosing agents; (9) Incomplete clinical data; (10) Patients who have been receiving long-term anticoagulation therapy; (11) Patients with less than 6 months of follow-up time; (12) Abnormal coagulation function, platelet function, or platelet count; (13) Patients or their families who do not consent to endoscopic sclerotherapy for hemorrhoids or participation in the clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall efficacy;Postoperative pain;Anal function;Quality of life;C-reactive protein, CRP; | — |
Secondary
| Measure | Time frame |
|---|---|
| Surgery duration and intraoperative bleeding;Postoperative complications;Length of hospital stay; | — |
Countries
China
Contacts
Public ContactMiao Wu; Cairong Hu
The Second People's Hospital of Yibin
Outcome results
None listed